0001209191-17-048106.txt : 20170808
0001209191-17-048106.hdr.sgml : 20170808
20170808165422
ACCESSION NUMBER: 0001209191-17-048106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170804
FILED AS OF DATE: 20170808
DATE AS OF CHANGE: 20170808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NAZARIAN DANA
CENTRAL INDEX KEY: 0001455837
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10079
FILM NUMBER: 171015489
MAIL ADDRESS:
STREET 1: 198 CHAMPION COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYPRESS SEMICONDUCTOR CORP /DE/
CENTRAL INDEX KEY: 0000791915
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 942885898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0117
BUSINESS ADDRESS:
STREET 1: 198 CHAMPION COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 4089432600
MAIL ADDRESS:
STREET 1: 198 CHAMPION COURT
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-04
0
0000791915
CYPRESS SEMICONDUCTOR CORP /DE/
CY
0001455837
NAZARIAN DANA
198 CHAMPION COURT
SAN JOSE
CA
95134
0
1
0
0
EVP, Operations & Technology
Common Stock
2017-08-04
4
S
0
250075
14.1036
D
302657
D
Represents shares of Issuer common stock previously acquired by the Reporting Person upon vesting and settlement of restricted stock units and performance restricted stock units awarded to the Reporting Person under the Issuer's equity incentive plans. Restricted stock units and performance restricted stock units convert into common stock on a one-for-one basis upon vesting.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.205 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Pamela Tondreau, attorney-in-fact
2017-08-08